AMGFormer: Adaptive Multi-Granular Transformer for Brain Tumor Segmentation with Missing Modalities
This addresses the clinical unreliability of multimodal MRI segmentation for brain tumor diagnosis, offering a robust solution for medical imaging with missing data.
The paper tackled the problem of brain tumor segmentation with missing MRI modalities, which causes high performance variance in existing methods, and proposed AMGFormer to achieve stable segmentation with less than 0.5% variance across modality combinations and up to 92.44% Dice scores.
Multimodal MRI is essential for brain tumor segmentation, yet missing modalities in clinical practice cause existing methods to exhibit >40% performance variance across modality combinations, rendering them clinically unreliable. We propose AMGFormer, achieving significantly improved stability through three synergistic modules: (1) QuadIntegrator Bridge (QIB) enabling spatially adaptive fusion maintaining consistent predictions regardless of available modalities, (2) Multi-Granular Attention Orchestrator (MGAO) focusing on pathological regions to reduce background sensitivity, and (3) Modality Quality-Aware Enhancement (MQAE) preventing error propagation from corrupted sequences. On BraTS 2018, our method achieves 89.33% WT, 82.70% TC, 67.23% ET Dice scores with <0.5% variance across 15 modality combinations, solving the stability crisis. Single-modality ET segmentation shows 40-81% relative improvements over state-of-the-art methods. The method generalizes to BraTS 2020/2021, achieving up to 92.44% WT, 89.91% TC, 84.57% ET. The model demonstrates potential for clinical deployment with 1.2s inference. Code: https://github.com/guochengxiangives/AMGFormer.